Skip to main content
. 2019 Jul 5;8(10):4678–4687. doi: 10.1002/cam4.2378

Figure 2.

Figure 2

Maximum local and systemic toxicity experienced during the trial per patient divided by dose. The vaccine well tolerated with a single grade 3 systemic toxicity event